好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Antihypertensive Agent Utilization Patterns after Stroke: Analysis of a Nationwide Sample
Cerebrovascular Disease and Interventional Neurology
(-)
004
Authors/Disclosures
Nerses Sanossian, MD, FAAN (Department of Neurology, USC) Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma.
No disclosure on file
Ling Zheng, MBBS, PhD (University of Southern California) No disclosure on file
Gene Y. Sung, MD, MPH (U.S.C. Neurology) The institution of Dr. Sung has received research support from NIH.
Bruce I. Ovbiagele, MD, MSc, FAAN (San Francisco VA) Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.